TalkMarkets Posted - 3 hours ago

MDGL: A Promising Play In The Weight Loss Drug Space $NVO $MDGL https://talkmarkets.com/content/stocks--equities/mdgl-a-promising-play-in-the-weight-loss-drug-space?post=470224

Max9090 Posted - 9 hours ago

$NVO somebody loading same number of shares after hours

JuggernautRaider Posted - 10 hours ago

@Marten_Bag few of us would be tough enough to work at Workhorse. $WKHS should buy what’s left of $VEV and incorporate it in Ohio. God Bless the US! ~JeffReeNah Jay “BoneSaw” Conroy I played football at Hudson and then for Northwestern. I am cheering for Indiana over OSU. Also: 1) sell $NVO (Novo Nordisk) 2) hold $LLY (Indiana’s Eli Lilly) 3) buy $VKTX (superior GLP-1 and NASH asset - in California Biotech!!!)

jogabonito84 Posted - 10 hours ago

$IBRX $MRK $BNTX $PFIZER.NSE $NVO Buying IBRX under $10, feels like when I bought Apple in 2007 when the iPhone just came out. Anktiva and bladder cancer are just the beginning of a new paradigm in cancer treatment

betachaser Posted - 11 hours ago

$VKTX the whole sector is hurting - need tutes to come back. $nvo priced as a bargain, I had to grab some today. Don’t need to bet on buyouts, there are some strong pharma/biotechs that have been cut 30% in a month or two

VaxMeDaddy Posted - 11 hours ago

$MRNA "The Great Biotech Flippening" is an event where the majority of revenue switched from cure-based healthcare to preventative-based healthcare, causing the majority of revenue to switch from biotech companies focused on curing diseases like $LLY $NVO $VRTX to companies like $MRNA

PashaGainz Posted - 12 hours ago

$ALT obviously best in class and highly undervalued to anyone that can read and comprehend clear unbiased data. Men lie, women lie, NUMBERS DON'T! $XBI $NVO $MRK $AMGN

diamondoptionsinc Posted - 12 hours ago

$NVO breaking downtrend short-term and seeing some bullish flow today. Decent sized order on the January $110 Calls 🟢

7Billiards Posted - 12 hours ago

$ALT $MDGL $NVO $VKTX let’s all win

Sasquamch Posted - 13 hours ago

$NVO The entire WORKD IS USING THESE DRUGS! Everyone knows $150 is coming. then $200 then $300

Jamtrades Posted - 13 hours ago

$NVO next stop $107/107.6

TeaMartinez4 Posted - 13 hours ago

$NVO still here. I believe in the earnings.

BestRegards Posted - 13 hours ago

$LLY $NVO $HIMS Imagine investing in these companies and not doing full DD on them beforehand. I feel like every time I see one of your posts you're just discovering some groundbreaking piece of information that most longs have known for months if not years, and that's not to discourage any new people from investing in it, but why you wouldn't know this before risking your money is over my head. Congratulations, you became a professional on the subject of high drug prices in the US overnight yet still defend big pharma. "The poor NVO CEO is getting unfair blame for high prices" ☹️ Didn't you hold HIMS stock a few weeks ago? Are the holders only "lucky" the FDA is pulling this stunt because they stuck with the company instead of missing the run up from $18 where you sold?

Chillymango Posted - 13 hours ago

$NVO Chinese market !!!

Lagoule Posted - 14 hours ago

$NVO Long Term Investment!🤩👍💎🙌💎

JacoI3 Posted - 14 hours ago

$HIMS RFK is just ranting what everyone agrees with. Drugs that saves lives is too expensive for americans. But RFK is blaming Novo for overcharging americans “because they think we’re stupid” etc. That’s his arguement. But why are they in fact so expensive compared to everywhere else in the world? Is it really cause Novo is harvesting more money per dose? Or could it be “complicated”? The american system is what makes the prices of drugs higher than anywhere in the world. Greedy american politicians. Novo’s greed is not the main issue. “Drug industry executives often complain that they are unfairly blamed for high prices while other parties, including P.B.M.s and insurers, are profiting from a growing share of drug spending and saddling patients with high out-of-pocket costs. “The United States is the only country that allows middlemen, such as P.B.M.s, to profiteer on medicines unchecked” Meaning they pass on the bill to the consumer. Let’s see if RFK brings that up. $NVO $LLY

Max9090 Posted - 14 hours ago

@Sasquamch I’m all in no more liquidity. Average 103$

Ainu Posted - 14 hours ago

$NVO 120 soon

Jamtrades Posted - 14 hours ago

$NVO is worth we least $107

Sasquamch Posted - 15 hours ago

$NVO buybacks will continue into February. you should have filled your bags!

Sasquamch Posted - 15 hours ago

$NVO will soon punch back above $110 and then continue its journey! did you buy these lows?

FolikoInvest Posted - 15 hours ago

$NVO Novo Nordisk is not just maintaining its lead in the weight loss drug market; it's expanding it, with a remarkable 44% revenue increase in its obesity segment. As competition heats up, can this industry giant continue to innovate and meet the growing demand for effective weight-loss solutions? https://folikoinsights.com/article/NVO/2024/11/22/novo-nordisk-strengthens-its-lead-in-the-weight-loss-drug-market-amid-rising-competition-and-increas?cid=IgX0nrC2utnSfN7V

Me_plus Posted - 15 hours ago

$NVO volumen not even at 1m yet. It’s just short sellers letting it go up to short back later

Sasquamch Posted - 16 hours ago

$NVO $108 on the next stop

Jamtrades Posted - 16 hours ago

https://www.globenewswire.com/news-release/2024/11/22/2985718/0/en/HUTCHMED-Announces-Launch-by-Takeda-of-FRUZAQLA-fruquintinib-in-Japan.html is massive news for $LLY and... you should watch $NVO as well.

Yosef_Miller Posted - 16 hours ago

🚨 MYNZ Petra Brand Ambassador says to keep an eye on "BIG NEWS from the NFL." This is going to run parabolic soon, right after the healthcare giant Thermo Fisher ($210B mkt cap) partnered with Mainz to develop and launch together ColoAlert in US 🚀 Buy the dip now, the train is leaving very soon. $NVO $JNJ $ABBV

Sasquamch Posted - 16 hours ago

$NVO prepare yourselves for $146 news will floor you and drop your JAW

7Billiards Posted - 16 hours ago

last night I wrote that $ALT has better liver data than $mdgl and $vktx and better lean mass preservation than $nvo’s semaglutide with less adverse events Just wanted to hop on quick and point out that this is still true this morning.

Quantumup Posted - 19 hours ago

B.Riley🏁 $VKTX Buy/$109, based on its confidence in the long-term disruptive pot of VK2735 for the obesity/T2D/MASH landscape—YTD $VKTX has generated a best-in-indication Ph2 SQ / Ph1 oral🔬—expects competitive positioning to unlock sig value thru YE25E via $NVO $AMGN $RHHBY updates: $gpcr tern

BestRegards Posted - 1 day ago

$LLY $NVO $HIMS Why not lick big pharmas boot a little harder? The legit larger players in the compounding space aren't pushing a garage made product like you want people to believe. Sure it can't be FDA approved ONLY because of patent but 503B facilities it is produced in ARE FDA regulated. You already know this but conveniently leave it out of your argument. There's a shortage whether you like it or not but according to you no one should get treatment or better their lifestyle now and once shortage resolves you say they should pay exorbitant prices for what is essentially the same thing? It's a slap in the face that NVO is selling it to China for 1/6th of the cost of what they rip Americans off on. Some ideas 💡 Don't make people pay $1,200/mo then complain when they find a better solution for $200 since you can't even keep up with demand even though you're worth 1 trillion.